Developer docs
API playgroundTry for free, no card

Search company profiles

SpeechVive

Full company profile

uuid0002kpu

Namestring
SpeechVive
Websiteurl
speechvive.com
Company typeenum
Private
Founded yearint
2011
Short descriptiontext

SpeechVive is a Lafayette, Indiana-based medical technology company founded in 2011 that provides a communication solution for individuals with Parkinson's Disease. The private firm has raised approximately $5 million across five rounds from 2014 to 2020 and operates with 1-10 employees.

Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersLafayette, United States
HQ citystring
Lafayette
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Keyword5 values
Parkinson's speech device, communication aid, medical device, speech therapy technology, neurological rehabilitation
Industry2 codes
1Speech Recognition, Dictation & Medical Transcription Platforms
CodeHLACAAAIPrimaryYes
2Speech Sound Disorders (Articulation/Phonology) Intervention
CodeEDAKAEADPrimaryNo
NAICS code1 code
  • Offices of Physical, Occupational and Speech Therapists, and Audiologists621340
SIC code1 code
  • Surgical & Medical Instruments & Apparatus3841
Product category
Medical Devices for Parkinson's Speech Therapy
Social media profiles2 records
Cost components4 values
Technology or R&D, Personnel, Supply Chain, Marketing or Sales
GTM typeB2C
B2C
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

SpeechVive develops and sells a medical device-based communication solution for people with Parkinson's Disease who experience reduced vocal volume and unclear speech. The company's flagship product is a wearable device that provides real-time auditory feedback to encourage louder, clearer speech during everyday conversation. The offering is targeted at Parkinson's patients seeking non-pharmacological, non-traditional speech therapy support and is positioned as a clinically validated adjunct to standard speech-language pathology treatment.

Differentiator
Functional benefit
Problem solved
Product and service1 record
1SpeechVive Communication Device
CategoryMedical Device for Parkinson's Speech Therapy
No data
Peers8 records
1LSVT Global
TypeDirect peer
Description

LSVT Global delivers the Lee Silverman Voice Treatment (LSVT-LOUD), the gold-standard speech therapy protocol for Parkinson's Disease. It is the most directly comparable competitor to SpeechVive, addressing the same patient population with an evidence-based speech intervention, though delivered as a therapy protocol rather than a wearable device.

2Tobii Dynavox
TypeBroad incumbent
Description

Tobii Dynavox is a leading manufacturer of augmentative and alternative communication (AAC) devices and eye-tracking technology for individuals with communication impairments. It serves a broader population than SpeechVive (including ALS, cerebral palsy, and stroke) but overlaps in the assistive communication device category.

3PRC-Saltillo
TypeDirect peer
Description

PRC-Saltillo produces speech-generating devices and AAC solutions for individuals with speech impairments. While its primary focus is on non-verbal or minimally verbal users, the company addresses a clinically adjacent population to SpeechVive's Parkinson's patients.

4Lingraphica
TypeEmerging player
Description

Lingraphica designs speech-generating devices and apps primarily for people with aphasia (often post-stroke). Its target population is partially adjacent to SpeechVive's Parkinson's speech-impairment focus, and it represents a comparable medical-device-plus-software hybrid model.

5Constant Therapy Health
TypeEmerging player
Description

Constant Therapy Health provides a digital speech and cognitive therapy platform used by clinicians and patients for rehabilitation. It represents a software-based, scalable alternative to SpeechVive's device model, addressing overlapping neurological patient populations.

6Medtronic
TypeBroad incumbent
Description

Medtronic is a global medical device leader whose deep brain stimulation (DBS) systems are an established Parkinson's therapy. While not a direct competitor in speech devices, Medtronic's continued investment in Parkinson's therapeutics could indirectly affect SpeechVive's patient population and treatment paradigm.

7Abbott (Neuromodulation)
TypeBroad incumbent
Description

Abbott's neuromodulation business offers DBS systems for Parkinson's Disease. As with Medtronic, Abbott is a broad incumbent whose Parkinson's therapies could compete for the same clinical decision-making that SpeechVive relies on.

8InPen (by Medtronic)
TypeRegional player
Description

While primarily a diabetes device, Medtronic's InPen exemplifies the connected prescription medical device model relevant to SpeechVive's commercialization path. It is a regional/vertical peer in the prescription connected medical device category serving chronic disease patients.

Market position
Customer concentration

Classification, Details

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles3 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds5 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors8 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

SpeechVive

Medical Devices for Parkinson's Speech Therapyspeechvive.com

SpeechVive is a Lafayette, Indiana-based medical technology company founded in 2011 that provides a communication solution for individuals with Parkinson's Disease. The private firm has raised approximately $5 million across five rounds from 2014 to 2020 and operates with 1-10 employees.

SpeechVive firmographics

Firmographics
Name
SpeechVive
Website
https://speechvive.com
Company type
Private
Founded year
2011
Headcount range
1–10 employees
Short description
SpeechVive is a Lafayette, Indiana-based medical technology company founded in 2011 that provides a communication solution for individuals with Parkinson's Disease. The private firm has raised approximately $5 million across five rounds from 2014 to 2020 and operates with 1-10 employees.
Ownership category
akta.pro rank

SpeechVive industry classification

Industry
Product category
Medical Devices for Parkinson's Speech Therapy
NAICS
Offices of Physical, Occupational and Speech Therapists, and Audiologists (621340)
SIC
Surgical & Medical Instruments & Apparatus (3841)
akta.pro primary industry
Speech Recognition, Dictation & Medical Transcription Platforms (HLACAAAI)
akta.pro secondary industry
Speech Sound Disorders (Articulation/Phonology) Intervention (EDAKAEAD)

Keywords

  • Parkinson's speech device
  • Communication aid
  • Medical device
  • Speech therapy technology
  • Neurological rehabilitation

Where SpeechVive is headquartered

Location

Headquarters

HQ city
Lafayette
HQ country
United States
HQ region
North America

Markets served

SpeechVive business model

Business model
GTM type
B2C
Offering type
Hardware or Manufacturing
Cost components
Technology or R&D, Personnel, Supply Chain, Marketing or Sales

SpeechVive product offering

Product offering

Core offering

SpeechVive develops and sells a medical device-based communication solution for people with Parkinson's Disease who experience reduced vocal volume and unclear speech. The company's flagship product is a wearable device that provides real-time auditory feedback to encourage louder, clearer speech during everyday conversation. The offering is targeted at Parkinson's patients seeking non-pharmacological, non-traditional speech therapy support and is positioned as a clinically validated adjunct to standard speech-language pathology treatment.

Differentiator

Problem solved

Functional benefit

Products and services

  • SpeechVive Communication Device

Companies that use SpeechVive

Customer profile

Ideal customer profiles2 records

SpeechVive technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

SpeechVive competitors and assessment

Company assessment

Direct peers

  • LSVT Global: LSVT Global delivers the Lee Silverman Voice Treatment (LSVT-LOUD), the gold-standard speech therapy protocol for Parkinson's Disease. It is the most directly comparable competitor to SpeechVive, addressing the same patient population with an evidence-based speech intervention, though delivered as a therapy protocol rather than a wearable device.
  • PRC-Saltillo: PRC-Saltillo produces speech-generating devices and AAC solutions for individuals with speech impairments. While its primary focus is on non-verbal or minimally verbal users, the company addresses a clinically adjacent population to SpeechVive's Parkinson's patients.

Broad incumbents

  • Tobii Dynavox: Tobii Dynavox is a leading manufacturer of augmentative and alternative communication (AAC) devices and eye-tracking technology for individuals with communication impairments. It serves a broader population than SpeechVive (including ALS, cerebral palsy, and stroke) but overlaps in the assistive communication device category.
  • Medtronic: Medtronic is a global medical device leader whose deep brain stimulation (DBS) systems are an established Parkinson's therapy. While not a direct competitor in speech devices, Medtronic's continued investment in Parkinson's therapeutics could indirectly affect SpeechVive's patient population and treatment paradigm.
  • Abbott (Neuromodulation): Abbott's neuromodulation business offers DBS systems for Parkinson's Disease. As with Medtronic, Abbott is a broad incumbent whose Parkinson's therapies could compete for the same clinical decision-making that SpeechVive relies on.

Emerging players

  • Lingraphica: Lingraphica designs speech-generating devices and apps primarily for people with aphasia (often post-stroke). Its target population is partially adjacent to SpeechVive's Parkinson's speech-impairment focus, and it represents a comparable medical-device-plus-software hybrid model.
  • Constant Therapy Health: Constant Therapy Health provides a digital speech and cognitive therapy platform used by clinicians and patients for rehabilitation. It represents a software-based, scalable alternative to SpeechVive's device model, addressing overlapping neurological patient populations.

Regional players

  • InPen (by Medtronic): While primarily a diabetes device, Medtronic's InPen exemplifies the connected prescription medical device model relevant to SpeechVive's commercialization path. It is a regional/vertical peer in the prescription connected medical device category serving chronic disease patients.

Market position

Customer concentration

SpeechVive social profiles

Digital presence

SpeechVive financial estimates

Financial estimate

Revenue estimate

Valuation estimate

SpeechVive leadership team

Management profile

Number of profiles

Profiles3 records

SpeechVive funding detail

Funding detail

Funding overview

Funding rounds5 records

Investors8 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

SpeechVive M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about SpeechVive

What does SpeechVive do?

SpeechVive develops and sells a medical device-based communication solution for people with Parkinson's Disease who experience reduced vocal volume and unclear speech. The company's flagship product is a wearable device that provides real-time auditory feedback to encourage louder, clearer speech during everyday conversation. The offering is targeted at Parkinson's patients seeking non-pharmacological, non-traditional speech therapy support and is positioned as a clinically validated adjunct to standard speech-language pathology treatment.

When was SpeechVive founded?

SpeechVive was founded in 2011. It employs 1 to 10 people.

Where is SpeechVive based?

SpeechVive is headquartered in Lafayette, United States, in the North America region.

Who are SpeechVive's main competitors?

Direct peers on record are LSVT Global and PRC-Saltillo. Broad incumbents are Tobii Dynavox, Medtronic and Abbott (Neuromodulation). Emerging players are Lingraphica and Constant Therapy Health. InPen (by Medtronic) is listed as a regional player.

Does SpeechVive have an API?

No public API is recorded for SpeechVive.

What industry is SpeechVive in?

SpeechVive's product category is Medical Devices for Parkinson's Speech Therapy. Its primary akta.pro industry code is HLACAAAI, Speech Recognition, Dictation & Medical Transcription Platforms, with a secondary code of EDAKAEAD, Speech Sound Disorders (Articulation/Phonology) Intervention. Its NAICS code is 621340 and its SIC code is 3841.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
MassDeviceSpeechVive raises $1.5m for speech improvement deviceSpeechVive, a medical device company affiliated with Purdue University, has raised more than $1.5 million through a convertible note syndicate to scale its business operations. The funding will support the addition of sales personnel for expansion into Veterans Affairs hospitals and further efforts to secure reimbursement from Medicare and commercial insurers.Purdue UniversitySpeechVive raises over $1.5 million in syndicated funding round to accelerate growthSpeechVive Inc. announced the completion of a convertible note syndicated funding round to support business scaling efforts. The company plans to expand its sales team within Veterans Affairs hospitals and pursue reimbursement approvals from Medicare and commercial insurers.FinSMEsSpeechVive Raises $2.275M in Seed FundingSpeechVive, an Indianapolis startup developing speech-clarity devices for Parkinson's patients, raised $2.275M in seed funding. The company received a $1.3M NIH grant and $975K from BioCrossroads and other investors. The funds will build a telehealth platform for remote programming of the device.PR NewswireIndiana life sciences start-up garners more than $2 million to design, build telehealth platform for Parkinson's patientsSpeechVive, an Indiana start-up developing a medical device to improve speech clarity in Parkinson's patients, has secured over $2 million in funding including a $1.3 million NIH grant and $975,000 from BioCrossroads' Indiana Seed Fund II, The Purdue Foundry, and a private investor. The funding will be used to design, build, and test a telehealth platform enabling speech pathologists to remotely program the SpeechVive device, allowing the company to reach elderly and physically impaired patients who cannot travel to appointments. Approximately 89 percent of Parkinson's patients suffer from speech issues which the SpeechVive device can address through the Lombard Effect, an involuntary reflex that elicits louder and clearer speech.FinSMEsSpeechVive Completes $700K in Series A FundingSpeechVive, a developer of a speech aid device for Parkinson's disease, completed nearly $700,000 in Series A funding. Backers included Ambassador Enterprises, and the company will use the funds to support the U.S. sales launch of its behind-the-ear smart device.